Dr. Feldman Named 2024 WIELD Trailblazer
Women Inspiring and Elevating Leadership in Diabetes (WEILD) named Eva Feldman, M.D., Ph.D., as a woman shaping diabetes and metabolism research and care.
Author |
From WIELD's website:
The WIELD Advisory Board and “Elevate working group” of WIELD are proud to announce the list of Diabetes Trailblazers for 2024. These are women that have nominated by their peers and that have had a critical impact on research and/or care in the fields of diabetes, obesity, and metabolism.
Eva Feldman, MD
James W. Albers Distinguished University Professor of Neurology
Russel N. DeJong Professor of Neurology
Director, ALS Center of Excellence at Michigan Medicine
Director, NeuroNetwork for Emerging Therapies
University of Michigan
Website: https://medicine.umich.edu/dept/mneuronet/about/eva-l-feldman-md-phd
Twitter (X): @EvaFeldmanMDPhD
Expertise: Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease and has made numerous contributions to biomedical research and clinical care in many critical areas. Her primary focus has been on amyotrophic lateral sclerosis (ALS), brain health, and the neurologic complications of diabetes and obesity. She also has conducted pioneering research on developing stem cell therapies to treat these diseases.
In This Story
Eva L Feldman, MD, PhD
Professor
Featured News & Stories
Using genetic testing, doctors help patient find answers for her diabetes
Supplementing with peptides: Good for extra pep or a needless step?
A night of two national titles for U-M, as scientists and basketball players both triumph
A unique patient case inspiring research
New hope for early diabetes detection